Are you up to date on the latest evidence in FLT3-mutated AML? Challenge yourself with this AdaptiveMedEd activity exploring cutting-edge evidence on new developments in the management of FLT3-mutated AML. Customized learning pathways based on the speed and accuracy of your answers will provide you with real-time feedback and resources targeted to your level of knowledge. This curated education covers outcomes from clinical trials, recent guideline updates, and insights on timely testing for FLT3 mutation and incorporating FLT3 inhibitors into frontline treatment plans. Upon completion, you will receive a personalized downloadable resource with all of the information presented to you during the activity.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/overcoming-barriers-optimal-treatment-management-flt3-mutated-aml-frontline
- Start Date: 2024-09-26 05:00:00
- End Date: 2024-09-26 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Daiichi Sankyo, Inc. - Amount: 40000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest